Found 0 matching trials
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
PHASE1A pharmacodynamic study to evaluate the effect of AV-299 on exploratory pha...
Location
Investigational Site 1
Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
PHASE1The epidermal growth factor receptor (EGFR) is both oncogene and prognostic...
Location
UPMC Presbyterian
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer
PHASE1To identify the maximally tolerated dose of ficlatuzumab when combined with...
Location
Massachusetts General Hospital
A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma
PHASE1Phase 1 study to determine safety, tolerability, dose-limiting toxicities (...
Location
Investigational Site 2